Results 231 to 240 of about 15,083 (304)

Developmental Outcome at 36 Months in Tuberous Sclerosis: Are There any Modifiable Predictors? [PDF]

Epilepsy Curr
Joshi C.
europepmc   +1 more source

Pharmacogenetics of vigabatrin and clobazam [PDF]

, 2009
openaire   +2 more sources

Insights into Tuberous Sclerosis Complex : From Genes to Clinics. [PDF]

J Korean Neurosurg Soc
Kim SY.
europepmc   +1 more source

Vigabatrin, tiagabine, and visual fields

, 2003
Mark Lawden
openalex   +1 more source

Drug-Related Pyroglutamic Acidosis: Systematic Literature Review. [PDF]

J Clin Med
Scafetta T, Kovacs O, Milani GP, Bronz G, Lava SAG, Betti C, Vanoni F, Bianchetti MG, Faré PB, Camozzi P.   +9 more
europepmc   +1 more source

Anti-seizure Medication Induced Cognitive Impairment in Children with Epilepsy: A Narrative Review. [PDF]

Iran J Child Neurol
Armide N, Babaei M.
europepmc   +1 more source

Embracing the future: Neonatal screening for epileptic syndromes. [PDF]

Epilepsia
Nabbout R, Kuchenbuch M.
europepmc   +1 more source

Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy. [PDF]

Children (Basel)
Samanta D.
europepmc   +1 more source

Potentiality of Evaluating Flash Electroretinography with a Montage of Skin Electrodes Connecting the Inner Canthus to the Ear in Younger Children: A Pilot Study. [PDF]

Yonago Acta Med
Oguri M, Kanai S, Okanishi T, Kawaguchi T, Takamori T, Maegaki Y.   +5 more
europepmc   +1 more source

Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG. [PDF]

Epilepsia Open
Deckard E, Sathe R, Tabibzadeh D, Terango A, Groves A, Rajaraman RR, Nariai H, Hussain SA.   +7 more
europepmc   +1 more source